CCR5 Deficiency Is a Risk Factor for Early Clinical Manifestations of West Nile Virus Infection but not for Viral Transmission
Open Access
- 15 January 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (2), 178-185
- https://doi.org/10.1086/649426
Abstract
Background. West Nile virus (WNV) is a neurotropic flavivirus transmitted to humans by mosquito vectors. Homozygosity for CCR5Δ32, a complete loss-of-function mutation in CC chemokine receptor 5 (CCR5), has been previously associated with severe symptomatic WNV infection in patients who present with clinical disease; however, whether it acts at the level of initial infection or in promoting clinical progression is unknown. Methods. Here, we address this gap in knowledge by comparing CCR5Δ32 distribution among US blood donors identified through a comprehensive blood supply screening program (34,766,863 donations from 2003 through 2008) as either WNV true positive (634 WNV-positive cases) or false positive (422 WNV-negative control participants). All subjects self-reported symptoms occurring during the 2 weeks following blood donation using a standardized questionnaire. Results. No difference was observed in CCR5Δ32 homozygous frequency between the WNV-positive cases and WNV-negative control participants. However, CCR5Δ32 homozygosity was associated in cases but not controls with clinical symptoms consistent with WNV infection (P=.002). Conclusions. CCR5 deficiency is not a risk factor for WNV infection per se, but it is a risk factor for both early and late clinical manifestations after infection. Thus, CCR5 may function normally to limit disease due to WNV infection in humans.Keywords
This publication has 25 references indexed in Scilit:
- Maraviroc for Previously Treated Patients with R5 HIV-1 InfectionThe New England Journal of Medicine, 2008
- Analysis of Genetic Polymorphisms in CCR5, CCR2, Stromal Cell–Derived Factor–1, RANTES, and Dendritic Cell–Specific Intercellular Adhesion Molecule–3–Grabbing Nonintegrin in Seronegative Individuals Repeatedly Exposed to HIV‐1The Journal of Infectious Diseases, 2004
- Role for CCR5Δ32 Protein in Resistance to R5, R5X4, and X4 Human Immunodeficiency Virus Type 1 in Primary CD4+CellsJournal of Virology, 2004
- Transmission of West Nile Virus through Blood Transfusion in the United States in 2002The New England Journal of Medicine, 2003
- Transmission of West Nile Virus from an Organ Donor to Four Transplant RecipientsThe New England Journal of Medicine, 2003
- Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological surveyThe Lancet, 2001
- The West Nile Virus Outbreak of 1999 in New York: The Flushing Hospital ExperienceClinical Infectious Diseases, 2000
- Phenotypic Expressions of CCR5-Δ32/Δ32 HomozygosityJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: Absence of mutation among asians and pacific islandersInternational Journal of Infectious Diseases, 1999
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996